Key Takeaways
- Q1 2026 financial results scheduled for release after trading hours on May 7
- Market expectations point to a 13.88% price movement in RKLB stock post-announcement
- Analysts forecast approximately $190.9 million in quarterly revenue, representing 50%+ annual growth
- Projected loss per share between $0.04–$0.07, showing improvement from prior year’s -$0.12
- Analyst consensus price target ranges from $83.31–$89.00 with a “Moderate Buy” recommendation
Rocket Lab is set to unveil its Q1 2026 financial performance following Thursday’s market close on May 7 at 5:00 PM ET. Trading around $77 per share, RKLB stock values the aerospace manufacturer at approximately $43.9 billion in market capitalization.
The options market indicates anticipated volatility of 13.88% in either direction after earnings are released. This projection significantly exceeds the company’s typical post-earnings movement of 4.65% observed across the previous four reporting periods.
Analyst projections call for quarterly revenue around $190.99 million, marking an increase exceeding 50% compared to the same period last year. The Street consensus anticipates a per-share loss between $0.04 and $0.07, representing meaningful progress from the $0.12 deficit recorded in Q1 2025.
Beyond the financial figures, market participants are particularly interested in developments surrounding the Neutron rocket initiative.
Neutron represents a 43-meter partially reusable launch vehicle engineered for satellite deployment and freight operations. Current timelines suggest a maiden flight sometime between late 2026 and early 2027. If executed successfully, Neutron could position Rocket Lab as a viable competitor to SpaceX’s Falcon 9 platform.
Profitability Metrics and Contract Pipeline Under Scrutiny
Profitability indicators will receive considerable attention. Rocket Lab’s GAAP gross margin reached 34.4% throughout 2025, though sustained improvement remains necessary to achieve overall profitability.
The aerospace firm concluded Q4 2025 with an all-time high backlog totaling $1.85 billion. Stakeholders will be monitoring whether this pipeline is effectively translating into recognized revenue.
Executive Transactions and Institutional Position Changes
Regarding insider transactions, Chief Executive Peter Beck divested 18,857 shares on March 2 at $69.59 each. Chief Financial Officer Adam Spice similarly sold 62,744 shares on the identical date, generating approximately $4.37 million in proceeds.
Collectively, company insiders have liquidated $16.49 million in equity over the trailing 90-day window. Executive ownership currently represents 8.40% of outstanding shares.
Institutional capital has demonstrated contrasting behavior. Alliancebernstein expanded its holdings by 818.8% during Q3. Amundi boosted its investment by 308.4% within the identical timeframe.
State Street, Deutsche Bank, and Renaissance Technologies have similarly increased their allocations. Institutional ownership now comprises 71.78% of RKLB stock.
Within the analyst community, Needham reduced its price objective from $110 to $95 while maintaining a Buy recommendation. Wells Fargo launched coverage with an Equal Weight stance and $60 target. Roth MKM elevated its forecast from $90 to $100 alongside a Buy rating.
Cantor Fitzgerald affirmed an Overweight designation with an $85 projection. The mean analyst price target stands at $83.31, spanning a range from approximately $60 to $100.
RKLB maintains a consensus “Moderate Buy” recommendation from 17 analysts — comprising two Strong Buys, nine Buys, five Holds, and one Sell rating.
The equity has fluctuated between $20.23 and $99.58 throughout the past twelve months. Current technical indicators show the 50-day moving average at $72.14 and the 200-day at $68.10.
